Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Controlled Human Malaria Infection Transmission Model - Phase A
PACTR202108851511956Phase 1Not yet recruiting
- Sponsor
- University of Oxford
- Start
- Sep 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of PfSPZ Challenge in malaria, sponsored by University of Oxford. Primary endpoints: Safety and optimisation of sporozoite dose for infection success in individuals with moderate-high malaria exposure, Magnitude and frequency of adverse events and 1 more. Planned start Sep 2021; status: not yet recruiting.
02
Drugs
PfSPZ Challenge
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR202108851511956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202108851511956.